secwatch.observer — SEC 8-K summary
======================================

Issuer:     Medtronic plc (MDT)
CIK:        0001613103
Form:       8-K
Filed at:   2026-05-18T20:30:33+00:00
Accession:  0001628280-26-035959
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medtronic neuroscience president Brett Wall to depart; Kweli Thompson named successor
--------------------------------------------------------------------------------

- Brett Wall steps down as EVP & President, Neuroscience Portfolio; effective June 1, 2026.
- Dr. Kweli Thompson moves from SVP & President, Cardiac Rhythm Management to succeed him.
- Wall will remain an employee through September 1, 2026 to assist transition.
- Severance consistent with Medtronic's executive severance practices per 2025 proxy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1613103/000162828026035959/0001628280-26-035959-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1613103/000162828026035959/mdt-20260518.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-035959

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer